1. Tian JL, Zhang JS. Hepatic perfusion disorders: Etiopathogenesis and related diseases. World J Gastroenterol. 2006.
2. Gryspeerdt S, et al. Evaluation of hepatic perfusion disorders with double-phase spiral CT. Radiographics. 1997.
3. Lupescu IG, et al. Hepatic perfusion disorders: Computer-tomographic and magnetic resonance imaging. J Gastrointestin Liver Dis. 2006.
4. Quiroga S, at al. Improved diagnosis of hepatic perfusion disorders: Value of hepatic arterial phase imaging during helical CT. Radiographics. 2001.
5. Colagrande S, et al. Transient hepatic attenuation differences. AJR Am J Roentgenol. 2004.
6. Zhou X, et al. Hepatic perfusion disorder associated with focal liver lesions: Contrast-enhanced US patterns-correlation study with contrast-enhanced CT. Radiology. 2011.
7. Arai K, et al. Dynamic CT of acute cholangitis: early inhomogeneous enhancement of the liver. AJR Am J Roentgenol 2003.
8. Colagrande S, et al. Meaning and etiopathogenesis of sectorial transient hepatic attenuation differences (THAD) Radiol Med. 2003.
9. Wang FS, et al. The global burden of liver disease: The major impact of China. Hepatology. 2014.
10. Kim SW, et al. Transient arterial enhancement of the hepatic parenchyma in patients with acute cholangitis. J Comput Assist Tomogr 2009.
11. Byun JH, et al. Arterioportal shunt: Prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT. Radiology. 2004.
12. Hwang J, et al. Small (≤2 cm) HCC in patients with chronic liver disease: Comparison of gadoxetic acid-enhanced 3T MRI and multiphasic CT. Br J Radiol. 2012.
13.Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000; 343:931-936